EFFECTS OF ABATACEPT ON MONOCYTES IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：2
|
作者：
Bonelli, M. [1 ]
Ferner, E. [1 ]
Savitskaya, A. [1 ]
Blueml, S. [1 ]
Steiner, C-W [1 ]
Rath, E. [1 ]
Smolen, J. S. [1 ]
Scheinecker, C. [1 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2010年 / 69卷
关键词：
D O I：
10.1136/ard.2010.129668f
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A169
引用
收藏
页码：A67 / A67
页数：1
相关论文
共 50 条
  • [31] Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis - A randomized trial
    Kremer, Joel M.
    Genant, Harry K.
    Moreland, Larry W.
    Russell, Anthony S.
    Emery, Paul
    Abud-Mendoza, Carlos
    Szechinski, Jacek
    Li, Tracy
    Ge, Zhiyu
    Becker, Jean-Claude
    Westhovens, Rene
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (12) : 865 - 876
  • [32] Abatacept (CTLA-4Ig) Treatment Reduces Adhesion and Migratory Capacity of Monocytes in Patients with Rheumatoid Arthritis (RA)
    Bonelli, Michael
    Ferner, Elisabeth
    Hladik, Anastasiya
    Goeschl, Lisa
    Karonitsch, Thomas
    Kiener, Hans Peter
    Blueml, Stefan
    Steiner, Carl-Walter
    Bergmann, Michael
    Smolen, Josef
    Scheinecker, Clemens
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S321 - S322
  • [33] Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab
    Talmon, Maria
    Percio, Marcella
    Obeng, Joyce Afrakoma
    Ruffinatti, Federico A.
    Sola, Daniele
    Sainaghi, Pier Paolo
    Bellis, Emanuela
    Cusinato, Stefano
    Ianniello, Aurora
    Fresu, Luigia G.
    PLOS ONE, 2023, 18 (03):
  • [34] Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
    Yokoyama-Kokuryo, Waka
    Yamazaki, Hayato
    Takeuchi, Tsutomu
    Amano, Koichi
    Kikuchi, Jun
    Kondo, Tsuneo
    Nakamura, Seiji
    Sakai, Ryoko
    Hirano, Fumio
    Nanki, Toshihiro
    Koike, Ryuji
    Harigai, Masayoshi
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [35] Effect of Abatacept on Telomerase Activity of Lymphocytes of Patients with Rheumatoid Arthritis
    Otani, Kazuhiro
    Ito, Haruyasu
    Hirai, Kenichiro
    Noda, Kentaro
    Yoshida, Ken
    Kingetsu, Isamu
    Kurosaka, Daitaro
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [36] Abatacept suppresses the telomerase activity of lymphocytes in patients with rheumatoid arthritis
    Otani, Kazuhiro
    Kurosaka, Daitaro
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (06) : 1138 - 1144
  • [37] Abatacept: A novel therapy approved for the treatment of patients with rheumatoid arthritis
    Lisa Lundquist
    Advances in Therapy, 2007, 24 : 333 - 345
  • [38] PREDICTIVE FACTORS OF DISCONTINUATION OF THERAPY WITH ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Piantoni, S.
    Colombo, E.
    Tincani, A.
    Airo, P.
    Scarsi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 518 - 518
  • [39] Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis
    Piantoni, Silvia
    Colombo, Enrico
    Tincani, Angela
    Airo, Paolo
    Scarsi, Mirko
    CLINICAL RHEUMATOLOGY, 2016, 35 (04) : 1065 - 1069
  • [40] Efficacy and safety of abatacept in patients with rheumatoid arthritis with previous malignancy
    Kunishita, Yosuke
    Ichikawa, Kento
    Uzawa, Yuji
    Mitsuhashi, Masaki
    Yoshioka, Yuji
    Okubo, Tadanobu
    Nagaoka, Shouhei
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2023, 15
12345